• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉导管溶栓:低剂量尿激酶是否有相同疗效?

Intravenous catheter declotting: same outcomes with lower dose urokinase?

作者信息

Juvé Maria Eulàlia

机构信息

Department of Nursing Education and Research, Bellvitge University Hospital, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

J Infus Nurs. 2003 Jul-Aug;26(4):245-51. doi: 10.1097/00129804-200307000-00010.

DOI:10.1097/00129804-200307000-00010
PMID:12869858
Abstract

This study aims to assess, in terms of catheter salvage and economic cost, the effect of a low dose (2000 IU) urokinase lock technique to clear multilumen central venous catheters (CVC) and peripherally inserted central catheters (PICCs) when occluded. A total of 100 catheters were included in the analysis. Results indicate this lower dose technique to be effective in restoring the patency of multilumen CVCs, but not as effective when clearing PICCs. No catheters were lost because of occlusion.

摘要

本研究旨在从导管挽救和经济成本方面,评估低剂量(2000国际单位)尿激酶封管技术在清除多腔中心静脉导管(CVC)和外周静脉穿刺中心静脉导管(PICC)堵塞时的效果。分析共纳入100根导管。结果表明,这种低剂量技术在恢复多腔CVC通畅方面有效,但在清除PICC堵塞时效果不佳。没有导管因堵塞而丢失。

相似文献

1
Intravenous catheter declotting: same outcomes with lower dose urokinase?静脉导管溶栓:低剂量尿激酶是否有相同疗效?
J Infus Nurs. 2003 Jul-Aug;26(4):245-51. doi: 10.1097/00129804-200307000-00010.
2
Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases.尿激酶用于恢复血液肿瘤疾病患儿功能失常或堵塞的中心静脉导管的通畅性。
Support Care Cancer. 2004 Dec;12(12):840-3. doi: 10.1007/s00520-004-0616-3. Epub 2004 Sep 9.
3
Administering urokinase for catheter clearance.使用尿激酶进行导管疏通。
Nursing. 1998 Dec;28(12):50-2. doi: 10.1097/00152193-199812000-00025.
4
Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters.
Appl Nurs Res. 2004 Nov;17(4):297-300.
5
Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.重组尿激酶在恢复阻塞的中心静脉通路装置通畅方面安全有效:一项多中心国际试验。
Crit Care Med. 2004 Oct;32(10):1990-6. doi: 10.1097/01.ccm.0000142706.01717.eb.
6
High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.大剂量透析中尿激酶用于恢复永久性中心静脉血液透析导管的通畅性。
Am J Kidney Dis. 1998 May;31(5):841-7. doi: 10.1016/s0272-6386(98)70054-x.
7
Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients.阿替普酶用于治疗外周静脉穿刺中心静脉导管堵塞:240例患者的安全性和有效性
J Vasc Interv Radiol. 2004 Jan;15(1 Pt 1):45-9. doi: 10.1097/01.rvi.000099538.29957.f7.
8
The effect of different flushing and locking techniques on catheter occlusion rates in central venous catheters: protocol for a multicentre, randomized controlled, parallel-group, open-label, superiority clinical trial.不同冲管和封管技术对中心静脉导管堵塞率的影响:一项多中心、随机对照、平行组、开放标签、优效性临床试验方案
Trials. 2024 Jun 12;25(1):380. doi: 10.1186/s13063-024-08141-6.
9
Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study.尿激酶封管治疗带隧道血液透析导管血栓形成功能障碍的疗效:一项回顾性队列研究。
J Vasc Access. 2019 Jan;20(1):60-69. doi: 10.1177/1129729818779549. Epub 2018 Jun 12.
10
High dose urokinase for restoration of patency of occluded permanent central venous catheters in hemodialysis patients.
Clin Nephrol. 2010 Oct;74(4):297-302. doi: 10.5414/cnp74297.